Document is current
Any future updates will be listed below
-
Authors
Jaeger, Martin G. https://orcid.org/0000-0002-7985-9744
Schwalb, Björn https://orcid.org/0000-0003-2987-2622
Mackowiak, Sebastian D.
Velychko, Taras https://orcid.org/0000-0003-4087-3730
Hanzl, Alexander
Imrichova, Hana https://orcid.org/0000-0003-0385-1823
Brand, Matthias
Agerer, Benedikt https://orcid.org/0000-0002-0044-8396
Chorn, Someth
Nabet, Behnam https://orcid.org/0000-0002-6738-4200
Ferguson, Fleur M. https://orcid.org/0000-0003-4091-7617
Müller, André C.
Bergthaler, Andreas https://orcid.org/0000-0003-0597-1976
Gray, Nathanael S. https://orcid.org/0000-0001-5354-7403
Bradner, James E. https://orcid.org/0000-0002-2718-4415
Bock, Christoph https://orcid.org/0000-0001-6091-3088
Hnisz, Denes https://orcid.org/0000-0002-6256-1693
Cramer, Patrick https://orcid.org/0000-0001-5454-7755
Winter, Georg E. https://orcid.org/0000-0001-6606-1437
- License Information
-
More Information
Article History
Received: 2 December 2019
Accepted: 24 April 2020
First Online: 1 June 2020
Competing interests
: G.E.W., J.E.B. and B.N. are inventors on patent applications related to the dTAG system (WO/2017/024318, WO/2017/024319, WO/2018/148443, WO/2018/148440). The dTAG<sup>V</sup>-1 molecule is the subject of a patent application filed by Dana-Farber Cancer Institute. N.S.G. is a scientific founder, member of the scientific advisory board (SAB) and equity holder for C4 Therapeutics, Syros, Soltego, B2S, Gatekeeper and Petra Pharmaceuticals. The Gray laboratory receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voroni, Her2llc, Deerfield and Sanofi. J.E.B. is now an executive and shareholder of Novartis and has been a founder and shareholder of SHAPE (acquired by Medivir), Acetylon (acquired by Celgene), Tensha (acquired by Roche), Syros, Regenacy and C4 Therapeutics.
